Background: Life expectancy in white Americans has dropped during the last two decades compared to other major racial groups, and increase in mortality for poisoning, particularly by narcotics, is known to have been one of the contributing factors. However, the contribution of medicaments other than narcotics to mortality in different racial/age groups is less studied.
Introduction
During the last two decades, life expectancy in white Americans was dropping compared to other major racial groups (save for Native Americans). By 2006, life expectancy in Hispanics was about 2.1 years higher than in non-Hispanic whites; by 2014, that gap has grown to about 3.2 years ( Figure 4 in [1] ). Life expectancy in African Americans is consistently lower than in whites, though the gap has decreased significantly in the recent years ( Figure 4 in [2] ; Figure 4 in [1] ). In absolute terms, life expectancy in whites began to decline starting 2014 [1, 3] , together with the overall decline in life expectancy in the US starting 2015 [4] amid an ongoing epidemic of drug overdose deaths [5, 6] .
Several factors behind the relative decline in life expectancy in white Americans have been proposed, e.g. [4, 7] . In particular, as suggested by a study that compared midlife mortality for the 2013-2015 period vs. the 1999-2001 period [8] , major increases in mortality by poisoning, suicide, and liver disease took place in non-elderly white Americans compared to Hispanics and blacks. Moreover, those increases, particularly for deaths by poisoning, took place in both the Urban/Suburban and Rural Areas (Figure 1 in [8] ). Those long-term trends, particularly in midlife deaths by poisoning and drug overdose [9, 8] , suggest that misuse of biological substances such as narcotics [5, 6] , and possibly medicaments other than narcotics may have pernicious health-related effects, including contribution to mortality in different population groups, particularly white Americans and Native Americans [9] . We note that the rates of consumption of certain medicaments in white Americans are higher than in other racial groups (excluding Native Americans) [10] , including major differences in the rates of consumption of antibiotics [11] (with even higher rates of antibacterial uptake reported in Native Americans [12] ), psychotropic drugs [13] , including antidepressants [14, 15] , and sedative-hypnotic medications [16] [17] [18] . A number of studies, including meta-analyses, suggested elevated risks for mortality, including sudden cardiac death (SCD) associated with the use of various psychotropic drugs (both antipsychotics and antidepressants), as well as certain sedative-hypnotic drugs (benzodiazepines) [19] [20] [21] [22] [23] [24] , though firmly establishing causal links in such studies can be challenging [25] . For the case of antibiotics, our own work suggests an association between prescribing rates for certain antibiotics, particularly penicillins in the elderly, and mortality and hospitalization rates for septicemia [26, 27] , with that association presumably being mediated by antimicrobial resistance [28] . Further work is needed to gain a more comprehensive understanding of the effect of prescribing and misuse of different medication on health-related, including mortality outcomes.
In this paper, we study one of the more direct contributions of medication use to mortality, namely mortality that involves poisoning by medications. We note that the rise in the rates of mortality associated with narcotic, including opiate overdose is well-documented, e.g. [5, 6, 9] .
However, trends in mortality involving poisoning by medicaments other than narcotics in the US are apparently not well studied. Here, we utilized the US CDC Wonder mortality database [29] to examine trends in mortality involving poisoning by medicaments other than narcotics in different age/racial groups in the US. We hope that this initial analysis will lead to further study of the contribution of medicament use to mortality outcomes, including mortality that does not involve poising by medicaments present on the death certificate (e.g. [19] [20] [21] [22] [23] [24] ).
Methods

Data
We've extracted annual mortality data between 2000-2017 stratified by age group (25-34y, 35- 44y, 45-54y, 55-64y, 65-74y) and racial group (Hispanics, Non-Hispanic whites, Non-Hispanic blacks, Non-Hispanic Asian-Americans, Non-Hispanic Native Americans) from the US CDC Wonder database [29] . While the 1999 data are also available in [29] , there are apparent incompatibilities between the 1999 and the 2000 data in [29] for certain age/racial groups (particularly non-whites), possibly having to do with transition from ICD-9 to ICD-10 coding around that time [30] and other factors relating to coding. Those data were extracted for five categories of deaths 1. Deaths involving poisoning by drugs, medicaments, and other biological substances: ICD- Those data were used to calculate the mortality rates for different causes used in the regression analyses:
A. Rates of mortality involving poisoning by medicaments but not narcotics and psychodysleptics (ICD-10 codes T36-39.xx or T41-50.8 but not T40.xx present as either underlying or contributing causes of death) were obtained by subtracting mortality rates in category 2. above from the mortality rates in category 3. above.
B. Rates of mortality involving poisoning by psychotropic drugs but not narcotics and psychodysleptics (ICD-10 codes T43.xx but not T40.xx present as either underlying or contributing causes of death) were obtained by subtracting mortality rates in category 2.
above from the mortality rates in category 4. above.
C. Rates of mortality involving poisoning by sedative-hypnotic drugs but not narcotics (ICD-10 codes T42.3-42.4 but not T40.xx present as either underlying or contributing causes of death) were obtained by subtracting mortality rates in category 2. above from the mortality rates in category 5. above. D. Rates of mortality involving poisoning by narcotics and psychodysleptics were obtained as mortality rates in category 2. above.
Trends in mortality rates
For each age/racial group, we have regressed the corresponding annual rates of mortality involving poisoning by (A) medicaments but not narcotics and psychodysleptics; (B) psychotropic drugs but not narcotics and psychodysleptics; (C) sedative-hypnotic drugs but not narcotics and psychodysleptics; (D) narcotics and psychodysleptics (see previous subsection) against the calendar year. Given the apparent uptick in the trends for mortality involving poisoning by medicaments (including psychotropic drugs) but not narcotics and psychodysleptics in certain age/racial groups starting around 2012 ( Figures 3,4 ), the regression analyses were performed separately for the 2000-2011 period and the 2011-2017 period. The regression coefficient for the calendar year estimates the annual increase in the rate of mortality involving poisoning by corresponding substances in the given age/racial group during the corresponding time period.
Relative changes in mortality rates
In addition to the evaluation of trends in mortality for the different categories of deaths in different age/racial groups, we also calculated the relative (fold) increases in the rates of mortality involving poisoning by different substances for different age groups in the overall population of US adults. The mortality categories are (i) medicaments but not narcotics and psychodysleptics; (ii) psychotropic drugs but not narcotics and psychodysleptics; (iii) sedativehypnotic drugs but not narcotics and psychodysleptics; (iv) narcotics and psychodysleptics. We considered changes in average annual mortality rates for the 2015-2017 period vs. [2000] [2001] [2002] period, as well as for the 2011-2014 period vs. 2000-2002 period (to allow for the comparison with changes in prescribing rates for different medications in [31] ).
Spatial variability in the rates of mortality involving poisoning by different substances
In addition to temporal changes in the rates of mortality involving poisoning by different substances, we also look at state-specific rates of mortality involving poisoning by psychotropic drugs but not narcotics/psychodysleptics, as well as mortality involving poisoning by narcotics/psychodysleptics, including correlations between those state-specific rates. Figure 1 plots the annual rates of mortality (per 100,000 individuals) involving poisoning by drugs, medicaments, and other biological substances between 2000-2017 for the different age/racial groups. Figure 2 plots the annual rates of mortality involving poisoning by narcotics and psychodysleptics between 2000-2017 for the different age/racial groups. We note that most deaths involving poisoning by drugs, medicaments, and other biological substances are deaths involving poisoning by narcotics and psychodysleptics ( Figure 2 narcotics and psychodysleptics between 2000-2017 for the different age/racial groups. We note that those rates are lower than the rates of mortality involving poisoning by narcotics and psychodysleptics ( Figure 3 vs. Figure 2 ). The biggest increases in mortality rates involving poisoning by medicaments but not narcotics and psychodysleptics were in Non-Hispanic Native Americans, though for the initial time period (2000-2011), for the three oldest age groups (45-54y, 55-64y, 65-74y), the increases in the rates of mortality involving poisoning by medicaments but not narcotics and psychodysleptics in Non-Hispanic whites were similar to the corresponding increases in Non-Hispanic Native Americans. Figures 4 and 5 plot the annual rates of mortality involving poisoning by psychotropic drugs but not narcotics and psychodysleptics ( Figure 4 ) and sedative-hypnotic drugs but not narcotics and psychodysleptics ( Figure 5) between 2000-2017 for the different age/racial groups. The majority of deaths involving poisoning by medicaments but not narcotics and psychodysleptics, as well as most of the increases in those death rates were for deaths involving poisoning by psychotropic drugs but not narcotics and psychodysleptics (Figure 3 vs. 4). We also note that rates of mortality involving poisoning by psychotropic drugs but not narcotics and psychodysleptics are generally higher in Non-Hispanic Native Americans than in Non-Hispanic whites, while rates of mortality involving poisoning by sedative-hypnotic drugs but not narcotics and psychodysleptics in Non-Hispanic whites are on par with the corresponding rates for Non-Hispanic Native Americans (Figures 5 and 4). 4 suggest an apparent uptick in the trends for mortality involving poisoning by medicaments (including psychotropic drugs) but not narcotics and psychodysleptics in certain age/racial groups starting around 2012. Table 1 gives the estimates of the annual increase in the rate of mortality involving poisoning by medicaments but not narcotics and psychodysleptics in different age/racial groups between 2000-2011, as well as between 2011-2017 (Methods).
Results
Rates of mortality involving poisoning by drugs, medicaments and other biological substances
Rates of mortality involving poisoning by narcotics and psychodysleptics
Rates of mortality involving poisoning by sedative-hypnotic drugs (barbiturates or benzodiazepines) but not narcotics and psychodysleptics
Annual increases in the rates of mortality involving poisoning by medicaments but not narcotics and psychodysleptics between 2011-2017 are significantly higher than the corresponding increases during the 2000-2011 period, with the biggest relative change between the two time periods being in Non-Hispanic blacks. The greatest increases in rate of mortality involving poisoning by medicaments but not narcotics and psychodysleptics during each time period are in non-elderly Non-Hispanic Native Americans, followed by Non-Hispanic whites. Increases in mortality rates involving poisoning by medicaments but not narcotics and psychodysleptics for non-elderly Non-Hispanic whites are significantly higher than for non-elderly Hispanics, Non-Hispanic blacks, and Non-Hispanic Asian-Americans, except for the 2011-2017 period, when increases for aged 25-44y in Non-Hispanic whites were comparable to the corresponding increases in Hispanics (for aged 25-34y) and Non-Hispanic blacks ( Table 1) Table 2 suggests that most of increases in the rates of mortality involving poisoning by medicaments but not narcotics and psychodysleptics were for mortality involving poisoning by psychotropic drugs but not narcotics and psychodysleptics. Similarly to mortality involving poisoning by medicaments but not narcotics and psychodysleptics, the greatest increases in the rates of mortality involving poisoning by psychotropic drugs but not narcotics and psychodysleptics during each time period are in non-elderly Non-Hispanic Native Americans, followed by Non-Hispanic whites. For mortality involving poisoning by sedative-hypnotic drugs, the corresponding increases for the two time periods are similar (Tables 3), with the increases for the 2011-2017 period being considerably lower compared to the corresponding increases for psychotropic drugs but not narcotics and psychodysleptics. Table 4 presents the estimates of annual increases in mortality rates involving poisoning by narcotics and psychodysleptics between 2000-2011, as well as between 2011-2017. Some of the largest increases in those rates are notably higher than the increases in the rates of mortality involving poisoning by medicaments but not narcotics and psychodysleptics (Table 4 vs. 1). For the 2000-2011 period, for younger age groups (25-54y), the largest increases in mortality rates involving poisoning by narcotics and psychodysleptics were in Non-Hispanic Native Americans and Non-Hispanic whites, with the corresponding rates of mortality in Hispanics and Non-Hispanic blacks decreasing for ages 35-44y; for older age groups (ages 55-74y), the largest increase between 2000-2011 was in Hon-Hispanic blacks. For the 2011-2017 period, for persons aged 25-44y, the biggest increases in the rates of mortality involving poisoning by narcotics and psychodysleptics were in Non-Hispanic whites, followed by Non-Hispanic Native Americans/Non-Hispanic Blacks; for persons aged over 45y, the biggest increases in the rates of mortality involving poisoning by narcotics and psychodysleptics between 2011-2017 were in Non-Hispanic blacks, followed by Non-Hispanic whites, then Non-Hispanic Native Americans.
2000-2011 period
Increases in the rates of mortality involving poisoning by narcotics and psychodysleptics between 2011-2017 were lowest in Non-Hispanic Asians. Table 5 shows significant increases in mortality involving poisoning, particularly by narcotics and psychodysleptics (especially in persons aged 55-74y), as well as psychotropic medications, particularly for adults aged 45-64y. Increases in the rates of mortality involving poisoning by psychotropic medications but not narcotics and psychodysleptics for the 2011-2014 period vs. 2000-2002 period were greater than the corresponding increases in the rates of prescribing for those medications, particularly for adults aged 45-64y (Table 5 vs. [31] ).
Increases in the rates of mortality involving poisoning by sedative-hypnotic medications but not narcotics and psychodysleptics for the 2011-2014 period vs. 2000-2002 period were greater than the corresponding increases in the rates of prescribing for those medications for adults aged 45-64y (Table 5 vs. [31] ).
There were no correlations between state-specific rates of mortality involving poisoning by psychotropic drugs but not narcotics/psychodysleptics and state-specific rates of mortality involving poisoning by narcotics/psychodysleptics during the 2013-2017 period; those correlation were -0.06(-0.33,0.22) for persons aged 45-64y, and -0.16(-0.42,0.12) for persons aged 25-44y. Table 6 presents the 20 states with the highest rates of mortality involving poisoning by psychotropic drugs but not narcotics/psychodysleptics, as well as the 20 states with the highest rates of mortality involving poisoning by narcotics/psychodysleptics per 100,000 persons aged 45-64y during the 2013-2017 period. Those lists of states are quite different, with a notable presence of westerns states among those with the highest rates of mortality involving poisoning by psychotropic drugs but not narcotics/psychodysleptics vs. a notable presence of eastern (particularly northeastern) states among those with the highest rates of mortality involving poisoning by narcotics/psychodysleptics. 
Discussion
There is a long-term decline in life expectancy for Non-Hispanic whites relative to other major racial groups in the US (except for Native Americans) [1] , and increases in midlife mortality by poisoning, suicide and liver disease in Non-Hispanic whites are known to have been greater than for other major racial groups [8] . This suggests that consumption and misuse of various biological substances contributes to the relative decline in life expectancy for Non-Hispanic whites (as well as Native Americans [9, 3] ). While the rise in mortality by narcotic, including opiate poisoning, particularly during the most recent years in well documented ( [5, 9] ), our understanding of the contribution of medicaments other than narcotics to mortality in different racial/age groups is more limited. In this study, we have shown significant increases in the rates of mortality involving poisoning by medicaments other than narcotics in different age/racial groups, both for the 2000-2011 period, and even more so for the 2011-2017 period. Those increases were particularly large in non-elderly Non-Hispanic Native Americans and whites. The majority of deaths involving poisoning by medicaments other than narcotics, as well as most of the increases in those death rates were for deaths involving poisoning by psychotropic medications. Significant increases in prescribing for antidepressants, antipsychotic and sedativehypnotic drugs in different age subgroups of adults took place during the study period [31] . For example, for the 2011-2014 period, 17.5% of US adults aged 45-64y and 18.7% of those aged 65-74y reported receiving antidepressant medications during the last 30 days, compared to 10.5% and 9.3% correspondingly for the 1999-2002 period. At the same time, increases in the rates of mortality involving poisoning by psychotropic medications but not narcotics and psychodysleptics were greater than increases in prescribing for psychotropic medications, particularly for persons aged 45-64y (Table 5 vs. [31] ), which might be different from the case of certain other countries, e.g. [32] . While rates of mortality involving poisoning by medicaments other than narcotics are lower than the rates of mortality involving poisoning by narcotics, medication use/misuse may have long-term pernicious effects on health, including mortality that does not involve poisoning by medicaments present on a death certificate. Indeed, a number of studies, e.g. [19] [20] [21] [22] [23] [24] have suggested elevated risks for mortality and other health-related outcomes associated with the use of psychotropic medications (both antipsychotic medications and antidepressants) and sedative-hypnotic medications (benzodiazepines). Our own work suggests associations between rates of prescribing for penicillins, and rates of mortality and hospitalization for septicemia in older adults [25, 26] . Additionally, rates of consumption of certain medications, particularly psychotropic drugs, sedative-hypnotic medications and antibiotics in Non-Hispanic whites are higher than in other major racial groups (save for Native Americans) [10] [11] [12] [13] [14] [15] [16] [17] [18] , and those differences have an effect on health-related, including mortality outcomes [19] [20] [21] [22] [23] [24] [25] [26] . Our results, as well as other work, e.g. [19] [20] [21] [22] [23] [24] [25] [26] (Table 4) , with the opposite being true for increases in mortality involving poisoning by medicaments but not narcotics and psychodysleptics (Table 1) , etc. Another possible contributing factor to the increase in the rates of mortality involving poisoning by medicaments but not narcotics and psychodysleptics is change in diagnostic/coding criteria. However, it is unlikely that such changes, if they indeed took place, would be very different for different population groups, while growth in the rates of mortality involving poisoning by medicaments but not narcotics and psychodysleptics is notably higher for some age/racial groups compared to others. For example, there were no discernible changes in the rates of mortality involving poisoning by medicaments but not narcotics and psychodysleptics in Non-Hispanic blacks aged 34-54y between 2000-2011 (Table 1) , while major changes in the corresponding mortality rates took place in Non-Hispanic whites and Non-Hispanic Native Americans. Another example is Non-Hispanic whites aged 55-64y vs. Non-Hispanic whites aged 65-74y. In the beginning of the study period, rates of mortality involving poisoning by medicaments but not narcotics and psychodysleptics were similar for the two age groups; however, subsequently those rates followed quite different trends for the two age groups (Figure 3 ). We believe that those differences in trends for different population groups are unlikely to be explained by differences in changes in diagnostic/coding criteria for those population groups, but rather by genuine differences in mortality trends. Finally, we don't know whether increases in prescribing or misuse have contributed to the increases in the rates of mortality involving poisoning by medicaments but not narcotics and psychodysleptics.
Significant increases in medication prescribing rates, particularly for sedative-hypnotic and antipsychotic drugs in adults aged 25-44y, and antidepressants in adults aged 45-74y did take place during the study period [31] . At the same time, increases in mortality involving poisoning by psychotropic, as well as sedative-hypnotic drugs, but not narcotics and psychodysleptics were generally greater than increases in prescribing for those medications, particularly for adults aged 45-64y (compare Table 5 to [31] ), suggesting the potential role of medication misuse in the increases in mortality by poisoning.
We believe that despite those limitations, our study shows significant increases in the rates of mortality involving poisoning by medicaments but not narcotics and psychodysleptics, especially poisoning by psychotropic drugs in different age/racial groups, particularly non-elderly Non-Hispanic Native Americans and whites, both between 2000-2011, and even more so between 2011-2017. Moreover, some of those increases in mortality rates have significantly exceeded the increases in prescription rates for the corresponding medications. Those results, as well as earlier studies showing associations between medication use and health-related, including mortality outcomes (e.g. [19] [20] [21] [22] [23] [24] [25] [26] ) further support the need for a comprehensive evaluation of the impact of prescribing and misuse of various medications on health and mortality outcomes in different population groups, as well as the related guidance regarding the use of those medications. Additionally, such analyses may help elucidate the role of medication use/misuse in the long-term decline in life expectancy in Non-Hispanic whites compared to other major racial groups (save for Native Americans) in the US [1] .
